Pharma's Almanac's "Road To" Experience documents exploratory trips, from cross-country races to multi-week global expeditions, where we engage with the scientists, industry leaders, CDMOs, biotechs, innovators, and policymakers driving progress across drug development and manufacturing.
Join Us On Our Next Road Trip
Explore how geography, culture, and constraint influence innovation
Hear firsthand insights from leaders shaping science, strategy, and scale
Meet life science experts where the work actually happens
Miles Traveled
Cities Visited
Countries Toured
SME Interviews
Episodes Published
2027
An exclusive invitation to join senior life sciences personnel at Paris's Musée Volant Salis aerodrome, Road to the Top will bring together industry leaders for high-level discussion, peer exchange, and a one-of-a-kind aviation experience. Join us as we explore how life science leaders reached the top and what it takes to stay there.
2025
A celebration of 30 years of That's Nice—Pharma's Almanac's parent company—across 30 New York City landmarks. Founders Nigel Walker and Mark Allen answered 30 of the most frequently asked questions about the agency, shared milestone stories from its history, and reflected on its evolution from a two-person creative house into the leading strategic agency for life sciences.
2024
An 18-day expedition exploring one of the world's most dynamic biotech markets. With Australia's high incidence of skin cancer, Road to the Max focused on oncology research and the industry leaders tackling cancer from new angles, all while embracing the trip's Mad Max inspiration, including conversations with members of the original cast, blending science, culture, and cinematic grit.
2023
The Transpacific Yacht Race: a voyage from California to Hawaii, with an added goal to study sea-borne microplastics along the route. The mission ultimately ended short of the finish due to the formidable hazards of the open sea, documenting how even the most carefully designed ventures can be undone, and what failure reveals about perseverance, adaptability, and limits.
2022
A 10-day journey across Ireland's rapidly growing biotech ecosystem, from global manufacturing hubs to emerging innovators, in an authentic DeLorean. This trip connects Ireland's deep history with its accelerating role in the global life sciences economy, capturing how policy and infrastructure converge to make the country a cornerstone of modern biopharma.
2021
The most ambitious "Road To" undertaken: a race against time to visit all 50 U.S. states in 50 days for an unmatched snapshot of America's life sciences landscape. From innovators and manufacturers to regional ecosystems and national leaders, Road to 50 States reveals the diversity, scale, and ingenuity driving biopharma across the entire country.
2020
A 25-day journey across Western Europe during the height of COVID-era travel restrictions. Lockdowns, border controls, and uncertainty shaped every mile. Still, the goal remained clear: understand how the European pharmaceutical community was responding to and helping manage one of the most challenging periods in modern biopharma history.
2017
The first "Road To" comprised a 12-day journey across 19 states from Boston to San Diego to attend the BIO International Convention. More than a road trip, Road to BIO explores what it takes to break through the cost, risk, and regulatory pressures that define pharmaceutical and biopharmaceutical development.
2027
An exclusive invitation to join senior life sciences personnel at Paris's Musée Volant Salis aerodrome, Road to the Top will bring together industry leaders for high-level discussion, peer exchange, and a one-of-a-kind aviation experience. Join us as we explore how life science leaders reached the top and what it takes to stay there.
2025
A celebration of 30 years of That's Nice—Pharma's Almanac's parent company—across 30 New York City landmarks. Founders Nigel Walker and Mark Allen answered 30 of the most frequently asked questions about the agency, shared milestone stories from its history, and reflected on its evolution from a two-person creative house into the leading strategic agency for life sciences.
2024
An 18-day expedition exploring one of the world's most dynamic biotech markets. With Australia's high incidence of skin cancer, Road to the Max focused on oncology research and the industry leaders tackling cancer from new angles, all while embracing the trip's Mad Max inspiration, including conversations with members of the original cast, blending science, culture, and cinematic grit.
2023
The Transpacific Yacht Race: a voyage from California to Hawaii, with an added goal to study sea-borne microplastics along the route. The mission ultimately ended short of the finish due to the formidable hazards of the open sea, documenting how even the most carefully designed ventures can be undone, and what failure reveals about perseverance, adaptability, and limits.
2022
A 10-day journey across Ireland's rapidly growing biotech ecosystem, from global manufacturing hubs to emerging innovators, in an authentic DeLorean. This trip connects Ireland's deep history with its accelerating role in the global life sciences economy, capturing how policy and infrastructure converge to make the country a cornerstone of modern biopharma.
2021
The most ambitious "Road To" undertaken: a race against time to visit all 50 U.S. states in 50 days for an unmatched snapshot of America's life sciences landscape. From innovators and manufacturers to regional ecosystems and national leaders, Road to 50 States reveals the diversity, scale, and ingenuity driving biopharma across the entire country.
2020
A 25-day journey across Western Europe during the height of COVID-era travel restrictions. Lockdowns, border controls, and uncertainty shaped every mile. Still, the goal remained clear: understand how the European pharmaceutical community was responding to and helping manage one of the most challenging periods in modern biopharma history.
2017
The first "Road To" comprised a 12-day journey across 19 states from Boston to San Diego to attend the BIO International Convention. More than a road trip, Road to BIO explores what it takes to break through the cost, risk, and regulatory pressures that define pharmaceutical and biopharmaceutical development.
The "Road To" Experience is built for and with the life sciences community.
Host a "Road To" stop at your facility
Participate as an interviewee or subject matter expert
Support a journey as a sponsor or partner
We'd love to hear from you.
Contact Us
